Trial intelligence / Profile preview

Efficacy and Safety of BABOR Serum and Cream for Facial Anti-aging

NCT06638905Phase 3Not yet recruiting

Sponsor
Cosmetic Laser Dermatology
Start
Oct 2024
Primary completion
Mar 2025
01

Overview

Phase 3, open-label, single-arm trial, sponsored by Cosmetic Laser Dermatology. Primary endpoints: Fitzpatrick-Goldman Classification of Wrinkling and Degree of Elastosis Scale at Day 90 and Evaluating Investigator Expert Grading Scales at Day 90. Planned start Oct 2024; status: not yet recruiting.

Beyond the preview

Go deeper on NCT06638905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06638905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call